Your Reports
01 / 08 LIVE · ACCESS-FILTERED LIVE
Awards Tracker
Forward 12-month FCV pipeline, randomization goals, and cancellation analytics across vaccine and non-vaccine studies.
$0.0M
FCV YTD
0
Studies
▲ 2 RISKNon-Vaccine tracking behind annual planNon-Vaccine FCV is well below its gross annual target — see the Non-Vaccine view for the exact gap.Cancellation rate elevated vs planGross cancellations are running well above the plan's built-in reserve rate.● 1 GOODVaccine ahead of plan on count and FCVBoth Vaccine count and FCV are tracking ahead of their annual targets.
Open report
IN PROGRESS
Sponsor vs Actuals
Sponsor-committed goals reconciled against actual enrollment and FCV by study and site.
No data committed yet
Q4 2026
New Site Tracker
Site selection through activation, mapped against rando goals and PPB by category.
Targeting Q4 2026
Q4 2026
Pipeline Conversion
Conversion rates from prospect to award across the full sponsor pipeline.
Targeting Q4 2026
Q4 2026
Revenue Waterfall
Bridge from target FCV to realized revenue, broken out by every adjustment in between.
Targeting Q4 2026
Q4 2026
SRD Dashboard
Super Regional Director performance and territory-level award tracking.
Targeting Q4 2026
Q4 2026
AR Dashboard
Accounts receivable aging and collections status across active sponsors.
Targeting Q4 2026
Q4 2026
Actual Revenue
Recognized revenue by month against forecast, reconciled to the GL.
Targeting Q4 2026